Beneficial Effects of Flavonoids Against Parkinson's Disease

Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal food
Main Authors Jung, Un Ju, Kim, Sang Ryong
Format Journal Article
LanguageEnglish
Published United States 01.05.2018
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause of PD remains unclear, it is widely accepted that oxidative stress, neuroinflammation, mitochondrial dysfunction, and insufficient support of neurotrophic factors are involved in the pathophysiology of the disease. However, novel regimens to prevent neurodegeneration and restore the degenerated nigrostriatal DA system are still required. In recent years, there has been a growing interest in naturally occurring phytochemicals, which are believed to reduce the risk of neurodegenerative diseases. This review provides an overview of the scientific literature concerning the preventive and protective roles of flavonoids, one of the largest families of phytochemicals, against PD. In addition to providing antioxidant and anti-inflammatory effects, flavonoids exhibit a neuroprotective effect by activating antiapoptotic pathways that target mitochondrial dysfunction and induce neurotrophic factors. This review suggests that flavonoids may be promising natural products for the prevention of PD and could potentially be utilized as therapeutic compounds against PD, even though there was no report showing that the treatment with flavonoids could restore the aberrant phenotypes of patients with PD.
AbstractList Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause of PD remains unclear, it is widely accepted that oxidative stress, neuroinflammation, mitochondrial dysfunction, and insufficient support of neurotrophic factors are involved in the pathophysiology of the disease. However, novel regimens to prevent neurodegeneration and restore the degenerated nigrostriatal DA system are still required. In recent years, there has been a growing interest in naturally occurring phytochemicals, which are believed to reduce the risk of neurodegenerative diseases. This review provides an overview of the scientific literature concerning the preventive and protective roles of flavonoids, one of the largest families of phytochemicals, against PD. In addition to providing antioxidant and anti-inflammatory effects, flavonoids exhibit a neuroprotective effect by activating antiapoptotic pathways that target mitochondrial dysfunction and induce neurotrophic factors. This review suggests that flavonoids may be promising natural products for the prevention of PD and could potentially be utilized as therapeutic compounds against PD, even though there was no report showing that the treatment with flavonoids could restore the aberrant phenotypes of patients with PD.
Author Jung, Un Ju
Kim, Sang Ryong
Author_xml – sequence: 1
  givenname: Un Ju
  surname: Jung
  fullname: Jung, Un Ju
  organization: 1 Department of Food Science and Nutrition, Pukyong National University , Busan, Korea
– sequence: 2
  givenname: Sang Ryong
  surname: Kim
  fullname: Kim, Sang Ryong
  organization: 3 Brain Science and Engineering Institute, Kyungpook National University , Daegu, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29412767$$D View this record in MEDLINE/PubMed
BookMark eNo1j0tLxDAUhYMozkOXbiU7V603aR4NuBnHGRUGdKHr4aZJJGObDk0V_PeOqKtzPjh8cGbkOPXJE3LBoGRQm-tdF0oOTJcCdH1EpkxKXWgFMCGznHcAUIlKn5IJN4JxrfSU3Nz65ENsIrZ0FYJvxkz7QNctfvapjy7TxRvGlEf6jMP7ofTpKtO7mD1mf0ZOArbZn__lnLyuVy_Lh2LzdP-4XGyKRnA1FoFLW6nADFobLNemRiWdsxZNY5loOCgTqkp4zT1DJg8guAMmndY_cz4nl7_e_YftvNvuh9jh8LX9v8G_AW-nSQE
CitedBy_id crossref_primary_10_1016_j_phyplu_2024_100558
crossref_primary_10_1016_j_lfs_2023_121995
crossref_primary_10_1016_j_neuint_2021_105135
crossref_primary_10_3390_chemosensors9100280
crossref_primary_10_1016_j_dscb_2022_100049
crossref_primary_10_3923_ijp_2024_942_955
crossref_primary_10_26599_FSHW_2022_9250035
crossref_primary_10_2174_1568026620666200416085330
crossref_primary_10_3390_biom12030371
crossref_primary_10_3390_ijms24076328
crossref_primary_10_1080_1028415X_2022_2073107
crossref_primary_10_29328_journal_jnnd_1001026
crossref_primary_10_62313_ijpbp_2022_22
crossref_primary_10_1007_s11011_020_00568_5
crossref_primary_10_2174_1871527320666210129122033
crossref_primary_10_2174_2210315512666220520150358
crossref_primary_10_3390_biom9070271
crossref_primary_10_3390_antiox13111364
crossref_primary_10_3390_ijms25021071
crossref_primary_10_5115_acb_19_119
crossref_primary_10_1007_s11011_022_01032_2
crossref_primary_10_1021_acschemneuro_1c00285
crossref_primary_10_4103_1673_5374_300461
crossref_primary_10_1016_j_ejmech_2025_117401
crossref_primary_10_1021_acsmedchemlett_3c00573
crossref_primary_10_1155_2022_5262677
crossref_primary_10_3390_ijms232012289
crossref_primary_10_7759_cureus_10921
crossref_primary_10_3390_ijms222111484
crossref_primary_10_1016_j_fitote_2024_106086
crossref_primary_10_11620_IJOB_2020_45_2_33
crossref_primary_10_3389_fphys_2023_1216948
crossref_primary_10_3389_fnagi_2020_00209
crossref_primary_10_3390_antiox12020280
crossref_primary_10_3390_antiox9070609
crossref_primary_10_3390_ijms21228653
crossref_primary_10_1080_87559129_2020_1721530
crossref_primary_10_1093_advances_nmaa112
crossref_primary_10_3390_antiox12030663
crossref_primary_10_1016_j_neuint_2019_104612
crossref_primary_10_4103_1673_5374_306082
crossref_primary_10_2174_1573401315666190801120306
crossref_primary_10_3390_antiox10020142
crossref_primary_10_3390_nu10050642
crossref_primary_10_1016_j_biopha_2023_115788
crossref_primary_10_3390_ijms22073338
crossref_primary_10_1016_j_jff_2021_104609
crossref_primary_10_3390_antiox13060645
crossref_primary_10_2174_0115680266303704240524080333
crossref_primary_10_1007_s00210_024_03462_4
crossref_primary_10_2174_1874609815666220819145845
crossref_primary_10_1111_jfbc_14426
crossref_primary_10_3390_molecules28052081
crossref_primary_10_1080_14737175_2021_1923479
crossref_primary_10_1093_nutrit_nuae079
crossref_primary_10_3390_antiox12071463
crossref_primary_10_1007_s13346_023_01407_7
crossref_primary_10_1016_j_intimp_2023_109698
crossref_primary_10_1002_cbf_3964
crossref_primary_10_1016_j_phanu_2020_100226
crossref_primary_10_3390_ijms22062953
crossref_primary_10_1016_j_neuroscience_2025_02_007
crossref_primary_10_2174_0118715249264078231214074107
crossref_primary_10_3390_neurolint16050082
crossref_primary_10_1080_10408398_2023_2299340
crossref_primary_10_3389_fphar_2024_1507108
crossref_primary_10_1016_j_bmcl_2024_129618
crossref_primary_10_1021_acschemneuro_2c00726
crossref_primary_10_1111_cns_13053
crossref_primary_10_3390_ijms24087318
crossref_primary_10_1111_cbdd_14619
crossref_primary_10_1016_j_cbi_2019_02_027
crossref_primary_10_1016_j_ejmech_2019_111862
crossref_primary_10_1016_j_ijbiomac_2019_09_148
crossref_primary_10_4103_1673_5374_301010
crossref_primary_10_3390_ijms21103624
crossref_primary_10_1080_10408398_2023_2171960
crossref_primary_10_4103_ejpi_EJPI_D_24_00083
crossref_primary_10_3389_fnins_2023_1153889
crossref_primary_10_1515_jcim_2018_0233
crossref_primary_10_1016_j_neuint_2019_104514
crossref_primary_10_1016_j_neuro_2022_03_004
crossref_primary_10_1007_s00109_021_02071_5
crossref_primary_10_2174_1570159X19666210524152817
crossref_primary_10_3390_antiox9070583
crossref_primary_10_3390_foods13121931
crossref_primary_10_3390_agriculture14020296
crossref_primary_10_1016_j_cclet_2024_110784
crossref_primary_10_1016_j_cbpc_2022_109500
crossref_primary_10_3390_molecules25071715
crossref_primary_10_3390_ijms23073625
crossref_primary_10_1016_j_neuro_2024_02_006
crossref_primary_10_1242_jeb_244556
crossref_primary_10_1016_j_clnesp_2022_01_023
crossref_primary_10_3390_molecules28062536
ContentType Journal Article
DBID NPM
DOI 10.1089/jmf.2017.4078
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Economics
Diet & Clinical Nutrition
EISSN 1557-7600
ExternalDocumentID 29412767
Genre Journal Article
GroupedDBID ---
0R~
29L
4.4
53G
5GY
9ZL
AAHBH
AAWTL
ABBKN
ABJNI
ACGFS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BNQNF
CS3
EBS
EJD
F5P
IAO
ICU
IHR
IM4
INH
MV1
NPM
NQHIM
O9-
P2P
RML
UE5
~KM
ID FETCH-LOGICAL-c426t-f25b36f19abbfb2798a65ddbba9cb14c2069f334e72e1a159f342d015d77b2792
IngestDate Thu Apr 03 08:16:55 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords flavonoids
neuroprotection
Parkinson's disease
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c426t-f25b36f19abbfb2798a65ddbba9cb14c2069f334e72e1a159f342d015d77b2792
PMID 29412767
ParticipantIDs pubmed_primary_29412767
PublicationCentury 2000
PublicationDate 2018-05-01
PublicationDateYYYYMMDD 2018-05-01
PublicationDate_xml – month: 05
  year: 2018
  text: 2018-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of medicinal food
PublicationTitleAlternate J Med Food
PublicationYear 2018
SSID ssj0003437
Score 2.4909947
SecondaryResourceType review_article
Snippet Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in...
SourceID pubmed
SourceType Index Database
Title Beneficial Effects of Flavonoids Against Parkinson's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/29412767
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-QwEA9-gPoiup7fSh5EH5au2yRtWvDFT0TQJxd8k6RJjhW3Fdo7uPvrnbSzWz-P05dQkrSE-TXJJDPzG0L2IutcYmIVWKl4IFIbB9pKHYAy7niScaVrio3rm_hyIK7uors2Z2YdXVLpXvb3w7iS76AKdYCrj5L9ArKTj0IFPAO-UALCUP4XxiewUCEDxHnrl3HxqH4XeTE0Zff4Jxz8y6rrY5sxzEuWnnFzYpR5r5eitb0ObCzMxMMGF4VB3r361RruR82tsnfh-1PgJoh3CGHSeuz1LK57kQy8je7DVbWfeFLSh1FNeSp73vT3sh8I5WlUi5ilImSyya_x79Y3JNfjpmkyDeq-z1_qL11wQ-WCS6RHhZEcvhqHJ3PGd98cDGoF4XaJLKIE6XED0zKZsnmHbJwNbUX3KdKvPtKbcfaDDpkfB4WXHTJ3jT4OK-SoRZUiqrRwtEWVIqp0gupBSRHTH2RwcX57ehlgjosgA92oChyLNI9dmCqtnWYyTVQcGaO1SjMdioz1Y5g0XFjJbKhA93RcMAM6nJHSd2erZCYvcrtOqEiY4mFmtBBSGONSzTOVKun6IjROuA2y1sjn_qkhMrkfS27z05YtstD-L9tk1sHMsTughlV6twbpGW_DMDY
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beneficial+Effects+of+Flavonoids+Against+Parkinson%27s+Disease&rft.jtitle=Journal+of+medicinal+food&rft.au=Jung%2C+Un+Ju&rft.au=Kim%2C+Sang+Ryong&rft.date=2018-05-01&rft.eissn=1557-7600&rft_id=info:doi/10.1089%2Fjmf.2017.4078&rft_id=info%3Apmid%2F29412767&rft_id=info%3Apmid%2F29412767&rft.externalDocID=29412767